Cost-effectiveness of the School-Based Asthma Therapy (SBAT) program

Katia Noyes1, Alina Bajorska, Susan Fisher

  • 1Department of Surgery, University of Rochester Medical Center, Rochester, NY 14642, USA. katia_noyes@urmc.rochester.edu

Pediatrics
|February 13, 2013
PubMed

Insights

The School-Based Asthma Therapy (SBAT) program significantly improves asthma symptom-free days for urban children. This asthma intervention is also cost-effective, offering savings compared to usual care.

Area of Science:

  • Pediatric Pulmonology
  • Public Health Interventions
  • Health Economics

Background:

  • Urban children face disproportionately high asthma rates.
  • Preventive asthma medication underuse is common in this population.
  • Existing care models may not adequately address asthma management in schools.

Purpose of the Study:

  • To evaluate the cost-effectiveness of the School-Based Asthma Therapy (SBAT) program.
  • To compare SBAT with usual care (UC) for pediatric asthma management.
  • To assess the impact of school-based asthma interventions on health outcomes and costs.

Main Methods:

  • A randomized trial involving 525 urban children (3-10 years) with asthma.
  • Intervention group received daily preventive medication at school; control group received usual care.
  • Outcomes measured included symptom-free days (SFDs), healthcare costs, and parental productivity losses.

Main Results:

  • SBAT yielded approximately 158 additional SFDs per 100 children per 30 days (P < .05).
  • The program incurred an additional cost of $4822 per 100 children monthly.
  • Net savings of $3240 per 100 children monthly were observed, with an incremental cost-effectiveness ratio of $10 per SFD gained.

Conclusions:

  • The School-Based Asthma Therapy (SBAT) program is effective in reducing asthma symptoms in urban children.
  • SBAT demonstrates significant cost-effectiveness compared to usual care.
  • School-based asthma management programs offer a viable strategy for improving pediatric asthma outcomes.
Abstract

Related Concept Videos

Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: &#946;2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...